Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 360

Results For "MED"

5418 News Found

Philips expands network of clinical partners for early diagnosis and treatment of lung cancer
Medical Device | March 28, 2022

Philips expands network of clinical partners for early diagnosis and treatment of lung cancer

Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases


Tata Capital Healthcare Fund II raises Rs 955 crore
News | March 28, 2022

Tata Capital Healthcare Fund II raises Rs 955 crore

The fund will take equity positions in India-focused healthcare and life sciences-related companies


NTT DATA launches hackathon for AI innovations in healthcare
Digitisation | March 28, 2022

NTT DATA launches hackathon for AI innovations in healthcare

Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
News | March 28, 2022

Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr

Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments


ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market
Biotech | March 28, 2022

ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market

The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain


Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
Biotech | March 27, 2022

Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis

There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022


Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
Hospitals | March 27, 2022

Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore

The MoU proposed investments in hospitals, pharmacies and laboratories in the state


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


NATHEALTH 8th annual summit in New Delhi from March 28-29.
News | March 26, 2022

NATHEALTH 8th annual summit in New Delhi from March 28-29.

More than 120 speakers and 5,000 delegates are expected to attend